MONTRONI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.846
EU - Europa 1.654
AS - Asia 1.316
SA - Sud America 225
Continente sconosciuto - Info sul continente non disponibili 40
AF - Africa 37
OC - Oceania 8
Totale 6.126
Nazione #
US - Stati Uniti d'America 2.813
SG - Singapore 517
SE - Svezia 370
UA - Ucraina 289
VN - Vietnam 263
RU - Federazione Russa 233
CN - Cina 207
BR - Brasile 169
DE - Germania 166
IE - Irlanda 148
DK - Danimarca 101
HK - Hong Kong 98
FR - Francia 95
GB - Regno Unito 73
FI - Finlandia 72
KR - Corea 66
TR - Turchia 66
IT - Italia 64
IN - India 21
CA - Canada 17
AR - Argentina 16
BD - Bangladesh 16
BE - Belgio 15
ZA - Sudafrica 14
CO - Colombia 11
IQ - Iraq 11
MA - Marocco 8
MX - Messico 7
VE - Venezuela 7
EC - Ecuador 6
AT - Austria 5
CI - Costa d'Avorio 5
JO - Giordania 5
MY - Malesia 5
NL - Olanda 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
KE - Kenya 4
NZ - Nuova Zelanda 4
PE - Perù 4
PY - Paraguay 4
UZ - Uzbekistan 4
CL - Cile 3
EG - Egitto 3
GE - Georgia 3
JP - Giappone 3
KZ - Kazakistan 3
LB - Libano 3
PH - Filippine 3
RO - Romania 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
ES - Italia 2
HN - Honduras 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
ME - Montenegro 1
MT - Malta 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 6.087
Città #
Singapore 353
Chandler 347
Jacksonville 286
Ashburn 246
Boardman 158
Dublin 147
Wilmington 142
San Jose 136
Fairfield 120
Hong Kong 95
Dallas 88
Ho Chi Minh City 75
Ann Arbor 70
Council Bluffs 70
Seattle 70
Houston 68
San Mateo 66
Woodbridge 64
Beijing 61
Hanoi 58
Lawrence 58
Princeton 58
Des Moines 53
New York 52
Lauterbourg 50
Hefei 49
The Dalles 49
Los Angeles 44
Buffalo 31
Moscow 30
San Diego 25
Cambridge 21
Brussels 15
Helsinki 15
Da Nang 13
Orem 13
Santa Clara 13
Chicago 11
Haiphong 11
Phoenix 10
São Paulo 10
Auburn Hills 9
Johannesburg 9
Seoul 9
Chennai 8
Ankara 7
Norwalk 7
Washington 7
Bogotá 6
Montreal 6
Rio de Janeiro 6
Stockholm 6
Thái Bình 6
Abidjan 5
Amman 5
Denver 5
Milan 5
San Francisco 5
Shanghai 5
Warsaw 5
Bến Tre 4
Cape Town 4
Charlotte 4
Hanover 4
Hải Dương 4
London 4
Nairobi 4
Nuremberg 4
Rome 4
Tashkent 4
Baghdad 3
Biên Hòa 3
Boston 3
Brasília 3
Dhaka 3
Guangzhou 3
Karbala 3
Kuala Lumpur 3
Lima 3
Marche 3
Montevideo 3
Munich 3
Ninh Bình 3
Porto Alegre 3
Pune 3
Quanzhou 3
São João del Rei 3
Tbilisi 3
Tokyo 3
Torre Annunziata 3
Wuhan 3
Almaty 2
Anápolis 2
Asunción 2
Auckland 2
Baku 2
Barranquilla 2
Baton Rouge 2
Bologna 2
Brooklyn 2
Totale 3.593
Nome #
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 179
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 178
Anticardiolipin antibodies expression in psoriasis 166
Higly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations 151
Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study. 143
Diagnosi sierologica nelle malattie autoimmuni non organo-specifiche. 140
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 134
Effects of cryopreservation on lymphocyte immunophenotype and function 132
Abnormal intracellular kinetics of cell –cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biological link between immune activation, accelerated T- cell turnover and high levels of apoptosis 130
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. 128
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. 127
Exogenous IL-2 administration corrects the cell cycle perturbation of lymphocytes from HIV-infected individuals 127
Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults; results of a 48-week open-label, equivalence trial (CAN 3014) 126
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? 125
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. 123
Interruption of antiretroviral therapy is associated with increased plasma cystatin C. 117
Il ruolo del Medico di Medicina Generale nella diagnosi precoce della malattia da HIV. 117
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naïve for Antiretrovirals 114
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. 113
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. 112
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. 112
I vaccini, da Jenner ai vaccini a DNA 108
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. 107
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. 106
Specific changes in the post-translational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus 105
Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. 105
Genotypic Resistance Tests for the Management of Structured Therapeutic Interruptions after Multiple Drug Failure: Prosecution 103
Major clinical outcomes in antiretroviral therapy (ART)-naïve participants and in those not receiving ART at baseline in the SMART study. 102
HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy 102
Unscheduled cyclin B expression and p34 cdc2 activation in T-lymphocytes from HIV patients 100
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. 98
Sexual behaviour of heterosexual individuals with HIV infection naïve for antiretroviral therapy in Italy . 97
Lo studio fenotipico di linfociti e altre cellule mononucleate. 97
Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status 97
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replicatio 96
Impact of Higly Active Antiretroviral Therapy on the Presenting Features and Outcome of Patients with Acquired Immunodeficiency Syndrome-Related Kaposi Sarcoma 94
Lo studio fenotipico delle cellule mononucleate, linee guida all'impiego clinico, alla lettura ed all'interpretazione nelle diverse condizioni morbose. 94
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. 93
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. 93
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 93
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. 92
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. 92
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 91
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 91
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. 91
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 87
Loss of CD127 (Interleukin-7 receptor) expression defines an expansion of “effector memory” CD8+Tcells in HIV-infected patients 87
Low prevalence of primary mutations associated with drug resistance in antiviral-naïve patients at therapy initiation 83
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina. 83
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study 83
Il paziente adulto con immunodeficienza. 79
Identikit della immunodeficienza da HIV. 73
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. 73
Infezione da HIV-1. 70
Il ruolo del Mmg nella diagnosi precoce della malattia da HIV. 69
La diagnosi immunologica delle Malattie Autoimmuni non Organo Specifiche 66
L’immunoricostituzione, un paesaggio dai mutevoli confini 66
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the I.Co.N.A study 66
Totale 6.126
Categoria #
all - tutte 25.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 96 2 61 8 21 8 43 26 56 23 84
2022/2023948 88 72 67 95 104 173 0 65 235 1 24 24
2023/2024404 85 11 17 73 70 62 8 8 0 4 12 54
2024/2025688 49 66 44 4 11 43 31 15 204 34 53 134
2025/20261.855 86 121 53 166 274 161 390 211 146 158 45 44
2026/2027103 46 57 0 0 0 0 0 0 0 0 0 0
Totale 6.126